Title,Abstract,Author Forename,Pubmed Data,PMID,Journal Title,Author Lastname
Effects of coenzyme Q10 and N-acetylcysteine on experimental poisoning by paracetamol in Wistar rats.,"[""Paracetamol (PAR) is a drug widely used in human and veterinary medicine as an analgesic and antipyretic, often involved in cases of intoxication. The most common clinical signs result from damage to red blood cells and hepatocytes, and this intoxication is considered a model for the induction of acute liver failure. In the present study, the hepatoprotective effects of coenzyme Q10 (CoQ10) and N-acetylcysteine (NAC) against experimental paracetamol (PAR) poisoning were analysed. Thirty-five adult Wistar rats (Rattus novergicus albinus) were randomly assigned to five groups, and thirty-one of these survived the treatments. Negative control group (CON-) received 1mL of 0.9% NaCl orally (PO). Other groups received 1.2g/kg of PAR (PO). Positive control group (CON+) received only PAR. NAC group received 800 mg/kg intraperitoneally (IP) of NAC 1h after the administration of PAR and at 12 h received 1mL of 0.9% NaCl, IP. The fourth group (CoQ10) received 1h and 12 h after intoxication, CoQ10 (10mg/kg IP). And the fifth group (NAC+CoQ10) received NAC (800mg/kg, IP) and CoQ10 (10mg/kg, IP). After 12 hours, the rats were euthanized and necropsied to collect liver and kidney tissues for histopathological evaluation and electronic microscopy. A single dose of PAR caused severe acute hepatitis. NAC couldn't reverse the liver and kidney damages. The group that received CoQ10 and NAC had moderate liver damage, while the group that received only CoQ10 had lower values of liver enzymes and mild liver and kidney damage. Animals that received treatment with CoQ10 or NAC+CoQ10 presented normal hepatocyte mitochondria and nuclei. Although CoQ10 couldn't reverse PAR organ damage, results indicate promising hepatoprotection in Wistar rats.""]",Rayanne Henrique Santana,"{'ReferenceList': [], 'History': [DictElement({'Year': '2023', 'Month': '2', 'Day': '14'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '5'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '18', 'Minute': '42'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '18', 'Minute': '42'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '13', 'Minute': '36'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('37607187', attributes={'IdType': 'pubmed'}), StringElement('10.1371/journal.pone.0290268', attributes={'IdType': 'doi'}), StringElement('PONE-D-23-03966', attributes={'IdType': 'pii'})]}",37607187,PloS one,da Silva
Changes in hospital consumption of opioid and non-opioid analgesics after colorectal endometriosis surgery.,"['The aim of this study was to analyze postoperative consumption of analgesics during hospitalization following colorectal surgery for endometriosis. We conducted a retrospective study at Tenon University Hospital, Paris, France from February 2019 to December 2021. One hundred sixty-two patients underwent colorectal surgery: eighty-nine (55%) by robotic and seventy-three (45%) by conventional laparoscopy. The type of procedure had an impact on acetaminophen and nefopam consumed per day: consumption for colorectal shaving, discoid resection, and segmental resection was, respectively, 2(0.5), 2.1(0.6), 2.4(0.6) g/day (p\u2009=\u200910-3), and 25(7), 30(14), 31(11) mg/day (p\u2009=\u20090.03). The total amount of tramadol consumed was greater following robotic surgery compared with conventional laparoscopy (322(222) mg vs 242(292) mg, p\u2009=\u20090.04). We observed a switch in analgesic consumption over the years: tramadol was used by 70% of patients in 2019 but only by 7.1% in 2021 (p\u2009<\u200910-3); conversely, ketoprofen was not used in 2019, but was consumed by 57% of patients in 2021 (p\u2009<\u200910-3). A history of abdominal surgery (OR\u2009=\u20090.37 (0.16-0.78, p\u2009=\u20090.011) and having surgery in 2020 rather than in 2019 (OR\u2009=\u20090.10 (0.04-0.24, p\u2009<\u200910<sup>-3</sup>)) and in 2021 than in 2019 (OR\u2009=\u20090.08 (0.03-0.20, p\u2009<\u200910<sup>-3</sup>)) were the only variables independently associated with the risk of opioid use. We found that neither clinical characteristics nor intraoperative findings had an impact on opioid consumption in this setting, and that it was possible to rapidly modify in-hospital analgesic consumption modalities by significantly reducing opioid consumption in favor of NSAIDS or nefopam.']",Adrien,"{'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Zondervan KT, Becker CM, Missmer SA (2020) Endometriosis. N Engl J Med 382(13):1244–1256', 'ArticleIdList': [StringElement('10.1056/NEJMra1810764', attributes={'IdType': 'doi'}), StringElement('32212520', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Weaver J, Chakladar S, Mirchandani K, Liu Z (2022) Surgical and pharmacological treatment patterns in women with endometriosis: a descriptive analysis of insurance claims. J Womens Health (Larchmt) 31(7):1003–1011', 'ArticleIdList': [StringElement('10.1089/jwh.2021.0060', attributes={'IdType': 'doi'}), StringElement('34846930', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lamvu G, Soliman AM, Manthena SR, Gordon K, Knight J, Taylor HS (2019) Patterns of prescription opioid use in women with endometriosis: evaluating prolonged use, daily dose, and concomitant use with benzodiazepines. Obstet Gynecol 133(6):1120–1130', 'ArticleIdList': [StringElement('10.1097/AOG.0000000000003267', attributes={'IdType': 'doi'}), StringElement('31135725', attributes={'IdType': 'pubmed'}), StringElement('6553518', attributes={'IdType': 'pmc'})]}, {'Citation': 'As-Sanie S, Soliman AM, Evans K, Erpelding N, Lanier RK, Katz NP (2021) Short-acting and long-acting opioids utilization among women diagnosed with endometriosis in the united states: a population-based claims study. J Minim Invasive Gynecol 28(2):297-306.e2', 'ArticleIdList': [StringElement('10.1016/j.jmig.2020.05.029', attributes={'IdType': 'doi'}), StringElement('32531340', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang W, Miller V, Wong M, Loring M, Morris S (2022) Intraoperative factors associated with more postoperative opioid use after laparoscopic hysterectomy. JSLS 26(3):e2022.00028', 'ArticleIdList': [StringElement('10.4293/JSLS.2022.00028', attributes={'IdType': 'doi'}), StringElement('35967961', attributes={'IdType': 'pubmed'}), StringElement('9355794', attributes={'IdType': 'pmc'})]}, {'Citation': 'Delgado SI, Koythong T, Turrentine MA, Sangi-Haghpeykar H, Guan X (2022) Postoperative opioid use for patients with chronic pelvic pain undergoing robotic surgery for resection of endometriosis. J Robotic Surg 16(2):421–427', 'ArticleIdList': [StringElement('10.1007/s11701-021-01259-8', attributes={'IdType': 'doi'})]}, {'Citation': 'Hill MV, McMahon ML, Stucke RS, Barth RJJ (2017) Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg 265(4):709–714', 'ArticleIdList': [StringElement('10.1097/SLA.0000000000001993', attributes={'IdType': 'doi'}), StringElement('27631771', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lovich-Sapola J, Smith CE, Brandt CP (2015) Postoperative pain control. Surg Clin North Am 95(2):301–318', 'ArticleIdList': [StringElement('10.1016/j.suc.2014.10.002', attributes={'IdType': 'doi'}), StringElement('25814108', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Moawad GN, Klebanoff JS, Muldoon O, North A, Amdur R, Tyan P (2021) Patterns of narcotic utilization in women undergoing hysterectomy for benign indications. J Gynecol Obstet Human Reprod 50(9):102181', 'ArticleIdList': [StringElement('10.1016/j.jogoh.2021.102181', attributes={'IdType': 'doi'})]}, {'Citation': 'Bazot M, Darai E, Hourani R, Thomassin I, Cortez A, Uzan S et al (2004) Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease. Radiology 232(2):379–389', 'ArticleIdList': [StringElement('10.1148/radiol.2322030762', attributes={'IdType': 'doi'}), StringElement('15205479', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Roseau G (2014) Recto-sigmoid endoscopic-ultrasonography in the staging of deep infiltrating endometriosis. World J Gastrointest Endosc 6(11):525–533', 'ArticleIdList': [StringElement('10.4253/wjge.v6.i11.525', attributes={'IdType': 'doi'}), StringElement('25400866', attributes={'IdType': 'pubmed'}), StringElement('4231491', attributes={'IdType': 'pmc'})]}, {'Citation': 'Bazot M, Thomassin I, Hourani R, Cortez A, Darai E (2004) Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis. Ultrasound Obstet Gynecol 24(2):180–185', 'ArticleIdList': [StringElement('10.1002/uog.1108', attributes={'IdType': 'doi'}), StringElement('15287057', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Daraï E, Ballester M, Chereau E, Coutant C, Rouzier R, Wafo E (2010) Laparoscopic versus laparotomic radical en bloc hysterectomy and colorectal resection for endometriosis. Surg Endosc 24(12):3060–3067', 'ArticleIdList': [StringElement('10.1007/s00464-010-1089-8', attributes={'IdType': 'doi'}), StringElement('20532571', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Calculating total daily dose of opioids for safer dosage. 2'}, {'Citation': 'Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196', 'ArticleIdList': [StringElement('10.1097/SLA.0b013e3181b13ca2', attributes={'IdType': 'doi'}), StringElement('19638912', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Balla A, Quaresima S, Subiela JD, Shalaby M, Petrella G, Sileri P (2018) Outcomes after rectosigmoid resection for endometriosis: a systematic literature review. Int J Colorectal Dis 33(7):835–847', 'ArticleIdList': [StringElement('10.1007/s00384-018-3082-y', attributes={'IdType': 'doi'}), StringElement('29744578', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Bendifallah S, Puchar A, Vesale E, Moawad G, Daraï E, Roman H (2021) Surgical outcomes after colorectal surgery for endometriosis: a systematic review and meta-analysis. J Minim Invasive Gynecol 28(3):453–466', 'ArticleIdList': [StringElement('10.1016/j.jmig.2020.08.015', attributes={'IdType': 'doi'}), StringElement('32841755', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ferrier C, Le Gac M, Kolanska K, Boudy A-S, Dabi Y, Touboul C et al (2022) Comparison of robot-assisted and conventional laparoscopy for colorectal surgery for endometriosis: a prospective cohort study. Int J Med Robot 18(3):e2382', 'ArticleIdList': [StringElement('10.1002/rcs.2382', attributes={'IdType': 'doi'}), StringElement('35178837', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zilberman S, Ballester M, Touboul C, Chéreau E, Sèbe P, Bazot M et al (2013) Partial colpectomy is a risk factor for urologic complications of colorectal resection for endometriosis. J Minim Invasive Gynecol 20(1):49–55', 'ArticleIdList': [StringElement('10.1016/j.jmig.2012.08.775', attributes={'IdType': 'doi'}), StringElement('23131702', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ballester M, Belghiti J, Zilberman S, Thomin A, Bonneau C, Bazot M et al (2014) Surgical and clinical impact of extraserosal pelvic fascia removal in segmental colorectal resection for endometriosis. J Minim Invasive Gynecol 21(6):1041–1048', 'ArticleIdList': [StringElement('10.1016/j.jmig.2014.04.018', attributes={'IdType': 'doi'}), StringElement('24858943', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N et al (2019) Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS®) society recommendations: 2018. World J Surg 43(3):659–695', 'ArticleIdList': [StringElement('10.1007/s00268-018-4844-y', attributes={'IdType': 'doi'}), StringElement('30426190', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Podda M, Saverio SD, Davies RJ, Atzeni J, Balestra F, Virdis F et al (2020) Prophylactic intra-abdominal drainage following colorectal anastomoses. A systematic review and meta-analysis of randomized controlled trials. Am J Surg 219(1):164–174', 'ArticleIdList': [StringElement('10.1016/j.amjsurg.2019.05.006', attributes={'IdType': 'doi'}), StringElement('31138400', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Mangalath AS, Kumar L, Sawant AB, Kesavan R, Ravindran G, Sunil R (2021) Comparison of analgesic requirements in robot-assisted versus conventional laparoscopic abdominal surgeries. J Anaesthesiol Clin Pharmacol 37(1):79–84', 'ArticleIdList': [StringElement('10.4103/joacp.JOACP_354_18', attributes={'IdType': 'doi'}), StringElement('34103828', attributes={'IdType': 'pubmed'}), StringElement('8174415', attributes={'IdType': 'pmc'})]}, {'Citation': 'Jin J, Chen Q, Min S, Du X, Zhang D, Qin P (2021) Prevalence and predictors of chronic postsurgical pain after colorectal surgery: a prospective study. Colorectal Dis 23(7):1878–1889', 'ArticleIdList': [StringElement('10.1111/codi.15640', attributes={'IdType': 'doi'}), StringElement('33738887', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Laganà AS, Rosa VLL, Rapisarda AMC, Valenti G, Sapia F, Chiofalo B et al (2017) Anxiety and depression in patients with endometriosis: impact and management challenges. IJWH 9:323–330', 'ArticleIdList': [StringElement('10.2147/IJWH.S119729', attributes={'IdType': 'doi'})]}, {'Citation': 'Lindberg M, Franklin O, Svensson J, Franklin KA (2020) Postoperative pain after colorectal surgery. Int J Colorectal Dis 35(7):1265–1272', 'ArticleIdList': [StringElement('10.1007/s00384-020-03580-4', attributes={'IdType': 'doi'}), StringElement('32318795', attributes={'IdType': 'pubmed'}), StringElement('7320040', attributes={'IdType': 'pmc'})]}, {'Citation': 'Shah A (2017) Characteristics of initial prescription episodes and likelihood of long-term opioid use—United States, 2006–2015. MMWR Morb Mortal Wkly Rep [Internet] 2017 [cited 2022 Dec 10] 66. Available from: https://www.facebook.com/CDCMMWR'}, {'Citation': 'Use and abuse of opioid analgesics - February 2019. 52'}, {'Citation': 'Evans MS, Lysakowski C, Tramèr MR (2008) Nefopam for the prevention of postoperative pain: quantitative systematic review. Br J Anaesth 101(5):610–617', 'ArticleIdList': [StringElement('10.1093/bja/aen267', attributes={'IdType': 'doi'}), StringElement('18796441', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Moffat AC, Kenny GN, Prentice JW (1990) Postoperative nefopam and diclofenac. Evaluation of their morphine-sparing effect after upper abdominal surgery. Anaesthesia 45(4):302–305', 'ArticleIdList': [StringElement('10.1111/j.1365-2044.1990.tb14737.x', attributes={'IdType': 'doi'}), StringElement('2337215', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wick EC, Grant MC, Wu CL (2017) Postoperative multimodal analgesia pain management with nonopioid analgesics and techniques: a review. JAMA Surg 152(7):691–697', 'ArticleIdList': [StringElement('10.1001/jamasurg.2017.0898', attributes={'IdType': 'doi'}), StringElement('28564673', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Grahn O, Lundin M, Chapman SJ, Rutegård J, Matthiessen P, Rutegård M (2022) Postoperative nonsteroidal anti-inflammatory drugs in relation to recurrence, survival and anastomotic leakage after surgery for colorectal cancer. Colorectal Dis 24(8):933–942', 'ArticleIdList': [StringElement('10.1111/codi.16074', attributes={'IdType': 'doi'}), StringElement('35108455', attributes={'IdType': 'pubmed'}), StringElement('9541253', attributes={'IdType': 'pmc'})]}, {'Citation': 'Kverneng Hultberg D, Angenete E, Lydrup M-L, Rutegård J, Matthiessen P, Rutegård M (2017) Nonsteroidal anti-inflammatory drugs and the risk of anastomotic leakage after anterior resection for rectal cancer. Eur J Surg Oncol 43(10):1908–1914', 'ArticleIdList': [StringElement('10.1016/j.ejso.2017.06.010', attributes={'IdType': 'doi'}), StringElement('28687432', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Milne TGE, Jaung R, O’Grady G, Bissett IP (2018) Nonsteroidal anti-inflammatory drugs reduce the time to recovery of gut function after elective colorectal surgery: a systematic review and meta-analysis. Colorectal Dis 20(8):O190–O198', 'ArticleIdList': [StringElement('10.1111/codi.14268', attributes={'IdType': 'doi'}), StringElement('29781564', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gupta A, Bah M (2016) NSAIDs in the treatment of postoperative pain. Curr Pain Headache Rep 20(11):62', 'ArticleIdList': [StringElement('10.1007/s11916-016-0591-7', attributes={'IdType': 'doi'}), StringElement('27841015', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kanellos P, Nirgianakis K, Siegenthaler F, Vetter C, Mueller MD, Imboden S (2021) Postoperative pain is driven by preoperative pain, not by endometriosis. J Clin Med 10(20):4727', 'ArticleIdList': [StringElement('10.3390/jcm10204727', attributes={'IdType': 'doi'}), StringElement('34682850', attributes={'IdType': 'pubmed'}), StringElement('8537544', attributes={'IdType': 'pmc'})]}]}], 'History': [DictElement({'Year': '2023', 'Month': '5', 'Day': '25'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2023', 'Month': '7', 'Day': '30'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '13', 'Minute': '42'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '13', 'Minute': '42'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '11', 'Minute': '30'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'aheadofprint', 'ArticleIdList': [StringElement('37606871', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s11701-023-01691-y', attributes={'IdType': 'doi'}), StringElement('10.1007/s11701-023-01691-y', attributes={'IdType': 'pii'})]}",37606871,Journal of robotic surgery,Crestani
Treatment of fever and associated symptoms in the emergency department: which drug to choose?,"[StringElement('Fever is a frequent cause of admission to the Emergency Department (ED) worldwide. Although it can be caused by a wide range of conditions, the most effective treatment based on its etiology is still undetermined.', attributes={'Label': 'OBJECTIVE', 'NlmCategory': 'OBJECTIVE'}), StringElement('This prospective, single-center, observational study enrolled adult patients who accessed the ED for fever. Physicians were free to administer paracetamol 1,000 mg (P), the combination paracetamol 500 mg/ibuprofen 150 mg (PI) or Ibuprofen 600 mg (I). The primary endpoint was both 1-degree and 1-point reduction in body temperature for all associated symptoms on the Numerical Rating Scale (NRS) after 1 hour (T1). The secondary endpoint was the reduction of at least 2 points on the NRS after two hours (T2). Adverse events, the need for rescue therapy, and the response based on the underlying etiology (bacterial, viral, or immune/neoplastic) were also evaluated.', attributes={'Label': 'PATIENTS AND METHODS', 'NlmCategory': 'METHODS'}), StringElement('324 patients (170 males, mean age 71±6 years) were enrolled: 187 had bacterial, 80 viral, and 57 neoplastic/inflammatory fever. Fever was treated with Paracetamol 1,000 mg (P) in 189 patients and with Paracetamol/Ibuprofen 500/150 mg (PI) in 135 subjects, while none of the patients were primarily treated with I. Based on the fever etiology P was administered to 113 patients with bacterial fever (59.8%), 48 patients with viral fever (25.4%), and 28 subjects with neoplastic/inflammatory fever (14.8%). PI was administered to 74 patients with bacterial fever (54.8%), 32 patients with viral fever (23.7%), and 29 subjects with neoplastic/inflammatory fever (21.5%). The primary endpoint was achieved by 126 patients, 70 of them (37.0%) were treated with P and 56 (41.5%) with PI (p=0.418). The secondary endpoint was achieved by 295 patients, 171 (90.5%) of them treated with P and 124 (91.9%) treated with PI (p=0.669). No significant differences were found between groups treated with P and PI concerning rescue therapy (15 vs. 6 patients; p=0.893). Interestingly, PI was more effective than P in patients with bacterial fever at T1 (P 33.6% vs. PI 48.6%; p=0.040), while efficacy of P and PI was similar at T2 for all kind of fever.', attributes={'Label': 'RESULTS', 'NlmCategory': 'RESULTS'}), StringElement('Paracetamol 1,000 mg represents the first choice for the treatment of fever in the ED, followed by Paracetamol/Ibuprofen 500/150 mg. Interestingly, Paracetamol/Ibuprofen combination resulted in being more effective in patients with bacterial fever one hour after its administration.', attributes={'Label': 'CONCLUSIONS', 'NlmCategory': 'CONCLUSIONS'})]",F,"{'ReferenceList': [], 'History': [DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '13', 'Minute': '42'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '13', 'Minute': '42'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '7', 'Minute': '27'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'ppublish', 'ArticleIdList': [StringElement('37606145', attributes={'IdType': 'pubmed'}), StringElement('10.26355/eurrev_202308_33308', attributes={'IdType': 'doi'}), StringElement('33308', attributes={'IdType': 'pii'})]}",37606145,European review for medical and pharmacological sciences,Franceschi
An Unusual IgE-Mediated Hypersensitivity: Two Case Reports of Paracetamol Allergy.,"['Paracetamol is one of the most commonly used analgesic and antipyretic agents worldwide, attributed in part to its excellent safety profile when administered at recommended doses. Paracetamol allergy is not common, and the majority of the reactions are related to the pharmacological action of cyclooxygenase 1 inhibition. Selective and Immunoglobulin E (IgE)-mediated hypersensitivity reactions are rare. In this article, the authors report two cases of paracetamol allergy in which the mechanism of IgE-mediated hypersensitivity was demonstrated by positive skin tests and basophil activation tests. We highlight the relevance of identifying the mechanism underlying the reaction since patients with IgE-mediated paracetamol allergies will be able to tolerate non-steroidal anti-inflammatory drugs.']",Rita,"{'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Comparative safety evaluation of non-narcotic analgesics. Andrade S, Martinez C, Walker A. J Clin Epidemiol. 1998;51:1357–1365.', 'ArticleIdList': [StringElement('10086830', attributes={'IdType': 'pubmed'})]}, {'Citation': 'COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL. Proc Natl Acad Sci U S A. 2002;99:13926–13931.', 'ArticleIdList': [StringElement('PMC129799', attributes={'IdType': 'pmc'}), StringElement('12242329', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hypersensitivity to nonsteroidal anti-inflammatory drugs: from pathogenesis to clinical practice. Mota I, Gaspar A, Morais-Almeida M. https://www.spaic.pt/client_files/rpia_artigos/hipersensibilidade-a-anti-inflamatorios-nao-esteroides-da-patogenese-a-pratica-clinica.pdf Rev Port Imunoalergologia. 2018;26:207–220.'}, {'Citation': 'Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Kowalski ML, Asero R, Bavbek S, et al. Allergy. 2013;68:1219–1232.', 'ArticleIdList': [StringElement('24117484', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Paracetamol hypersensitivity: clinical features, mechanism and role of specific IgE. Rutkowski K, Nasser SM, Ewan PW. Int Arch Allergy Immunol. 2012;159:60–64.', 'ArticleIdList': [StringElement('22555261', attributes={'IdType': 'pubmed'})]}, {'Citation': 'The accuracy of the diagnosis of suspected paracetamol (acetaminophen) hypersensitivity: results of a single-blinded trial. Kvedariene V, Bencherioua AM, Messaad D, Godard P, Bousquet J, Demoly P. Clin Exp Allergy. 2002;32:1366–1369.', 'ArticleIdList': [StringElement('12220477', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Selective hypersensitivity reactions to acetaminophen: a 13-case series. Rojas-Pérez-Ezquerra P, Sánchez-Morillas L, Gómez-Traseira C, Gonzalez-Mendiola R, Alcorta Valle AR, Laguna-Martinez J. J Allergy Clin Immunol Pract. 2014;2:343–345.', 'ArticleIdList': [StringElement('24811028', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Paracetamol hypersensitivity: a 5 year review. Malheiro D, Sousa M, Moreira A, Cadinha S, Silva JM. Clin Transl Allergy. 2014;4:0.'}, {'Citation': 'Selective anaphylaxis to paracetamol in a child. Couto M, Gaspar A, Morais-Almeida M. https://pubmed.ncbi.nlm.nih.gov/23092003/ Eur Ann Allergy Clin Immunol. 2012;44:163–166.', 'ArticleIdList': [StringElement('23092003', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Paracetamol allergy in clinical practice. Thompson G, Bundell C, Lucas M. Aust J Gen Pract. 2019;48:216–219.', 'ArticleIdList': [StringElement('31256492', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. Brockow K, Garvey LH, Aberer W, et al. Allergy. 2013;68:702–712.', 'ArticleIdList': [StringElement('23617635', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Paracetamol anaphylaxis. Martin JA, Lazaro M, Cuevas M, Alvarez-Cuesta E. Clin Exp Allergy. 1993;23:534.', 'ArticleIdList': [StringElement('8369983', attributes={'IdType': 'pubmed'})]}, {'Citation': '[Anaphylactic or anaphylactoid reactions to paracetamol. Report of 3 cases] Sabbah A, Sainte-Laudy J, Drouet M, Lauret MG, Loiry M. https://pubmed.ncbi.nlm.nih.gov/9221011/ Allerg Immunol (Paris) 1997;29:60–62.', 'ArticleIdList': [StringElement('9221011', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Anaphylaxis to paracetamol. Galindo PA, Borja J, Mur P, Feo F, Gómez E, García R. https://pubmed.ncbi.nlm.nih.gov/9816409/ Allergol Immunopathol (Madr) 1998;26:199–200.', 'ArticleIdList': [StringElement('9816409', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Paracetamol (acetaminophen) hypersensitivity. Paramo B, Gancedo Q, Cuevas M, Camo I, Martin J, Cosmes E. Ann Allergy Asthma Immunol. 2000;85:508–511.', 'ArticleIdList': [StringElement('11152174', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Acetaminophen anaphylaxis diagnosed by skin prick test. Numata T, Fukushi R, Ito T, Tsuboi R, Harada K. Allergol Int. 2016;65:490–491.', 'ArticleIdList': [StringElement('27460168', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Paracetamol allergy: a case of a 9-year-old female with history of atopy. Teles A, Ribeiro-Mourão F, Branco M, Araújo AR, Vieira T. Pediatr Allergy Immunol Pulmonol. 2021;34:80–82.', 'ArticleIdList': [StringElement('PMC8329691', attributes={'IdType': 'pmc'}), StringElement('34143688', attributes={'IdType': 'pubmed'})]}, {'Citation': 'The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Gamboa P, Sanz ML, Caballero MR, Urrutia I, Antépara I, Esparza R, de Weck AL. Clin Exp Allergy. 2004;34:1448–1457.', 'ArticleIdList': [StringElement('15347380', attributes={'IdType': 'pubmed'})]}, {'Citation': 'In vitro diagnosis of immediate drug hypersensitivity: should we go with the flow. Mangodt EA, Van Gasse AL, Decuyper I, et al. Int Arch Allergy Immunol. 2015;168:3–12.', 'ArticleIdList': [StringElement('26524156', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Recent applications of basophil activation tests in the diagnosis of drug hypersensitivity. Song WJ, Chang YS. Asia Pac Allergy. 2013;3:266–280.', 'ArticleIdList': [StringElement('PMC3826605', attributes={'IdType': 'pmc'}), StringElement('24260732', attributes={'IdType': 'pubmed'})]}]}], 'History': [DictElement({'Year': '2023', 'Month': '7', 'Day': '20'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '6', 'Minute': '44'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '6', 'Minute': '43'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '3', 'Minute': '38'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('37605667', attributes={'IdType': 'pubmed'}), StringElement('PMC10440018', attributes={'IdType': 'pmc'}), StringElement('10.7759/cureus.42240', attributes={'IdType': 'doi'})]}",37605667,Cureus,Limão
Medication use in a cohort of adults with chronic intestinal failure: A prospective cross-sectional study.,"[StringElement('Oral drug therapy may be compromised in chronic intestinal failure (IF) because of alterations in absorption and transit. Only scarce literature is available on which medication patients with chronic IF take in daily life. The aim was to describe the medication use in these patients.', attributes={'Label': 'BACKGROUND', 'NlmCategory': 'BACKGROUND'}), StringElement('A medication history was obtained from adults with chronic IF treated in our tertiary care IF center. Degree of polypharmacy, drug classes, Biopharmaceutics Classification System classes, route of administration, and formulation of drugs were analyzed.', attributes={'Label': 'METHODS', 'NlmCategory': 'METHODS'}), StringElement('From October 2019 until December 2020, 72 patients (35 patients with short bowel syndrome [SBS] and 37 patients without SBS) were included. Polypharmacy was seen in 85.7% of patients with SBS and 75.7% of patients without SBS. The top three drug classes were proton-pump inhibitors, vitamin D or acetaminophen, and antimotility medication or laxatives/benzodiazepines. Approximately 25% of the drugs were classified as Biopharmaceutics Classification System class I drugs. In patients with SBS (78%) and patients without SBS (74.9%), most medication was taken orally, requiring gastrointestinal absorption of the active substance to be pharmacologically active. Most of these medications (77% in patients with SBS and 80.8% in patients without SBS) were formulated as a capsule or tablet, requiring disintegration and dissolution in the gastrointestinal tract before absorption can take place.', attributes={'Label': 'RESULTS', 'NlmCategory': 'RESULTS'}), StringElement('Polypharmacy was observed in most patients with chronic IF. Most medication was taken orally in formulations requiring disintegration, dissolution, and gastrointestinal absorption, which could be compromised in chronic IF.', attributes={'Label': 'CONCLUSION', 'NlmCategory': 'CONCLUSIONS'})]",Barbara,"{'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Cuerda C, Pironi L, Arends J, et al. ESPEN practical guideline: clinical nutrition in chronic intestinal failure. Clin Nutr. 2021;40(9):5196-5220. doi:10.1016/j.clnu.2021.07.002'}, {'Citation': 'Pironi L, Hébuterne X, Van Gossum A, et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol. 2006;101(7):1633-1643. doi:10.1111/j.1572-0241.2006.00710.x'}, {'Citation': 'Jeppesen PB. Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure. JPEN J Parenter Enteral Nutr. 2014;38(1 suppl):8S-13S. doi:10.1177/0148607114520994'}, {'Citation': 'Kwak MJ, Chang M, Chiadika S, et al. Healthcare expenditure associated with polypharmacy in older adults with cardiovascular diseases. Am J Cardiol. 2022;169:156-158.'}, {'Citation': 'Osanlou R, Walker L, Hughes DA, Burnside G, Pirmohamed M. Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. BMJ Open. 2022;12(7):e055551.'}, {'Citation': 'Sheehan JL, Jacob J, Berinstein EM, et al. The relationship between opioid use and healthcare utilization in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2022;28(12):1904-1914. doi:10.1093/ibd/izac021'}, {'Citation': 'Santamaría MM, Villafranca JJA, Abilés J, et al. Systematic review of drug bioavailability following gastrointestinal surgery. Eur J Clin Pharmacol. 2018;74(12):1531-1545. doi:10.1007/s00228-018-2539-9'}, {'Citation': 'Severijnen R, Bayat N, Bakker H, Tolboom J, Bongaerts G. Enteral drug absorption in patients with short small bowel: a review. Clin Pharmacokinet. 2004;43(14):951-962. doi:10.2165/00003088-200443140-00001'}, {'Citation': 'Ward N. The impact of intestinal failure on oral drug absorption: a review. J Gastrointest Surg. 2010;14(6):1045-1051. doi:10.1007/s11605-009-1151-9'}, {'Citation': 'Hong WBT, Tan WK, Law LSC, Ong DEH, Lo EAG. Changes of drug pharmacokinetics in patients with short bowel syndrome: a systematic review. Eur J Drug Metab Pharmacokinet. 2021;46(4):465-478. doi:10.1007/s13318-021-00696-y'}, {'Citation': 'de Vries FEE, Reeskamp LF, van Ruler O, et al. Systematic review: pharmacotherapy for high-output enterostomies or enteral fistulas. Aliment Pharmacol Ther. 2017;46(3):266-273. doi:10.1111/apt.14136'}, {'Citation': 'Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-420. doi:10.1023/a:1016212804288'}, {'Citation': 'Committee for Medicinal Products for Human Use (CHMP). Guideline on the investigation of bioequivalence. Published January 29, 2010. Accessed September 1, 2022. https://www.ema.europa.eu/en/investigation-bioequivalence'}, {'Citation': 'US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. Published December 2017. Accessed September 1, 2022. https://www.gmp-compliance.org/guidelines/gmp-guideline/fda-guidance-for-industry-waiver-of-in-vivo-bioavailability-and-bioequivalence-studies-for-immediate-release-solid-oral-dosage-f'}, {'Citation': 'Farah K, Syed MFH, Madiha M, et al. Comparative analysis of biopharmaceutic classification system (BCS) based biowaiver protocols to validate equivalence of a multisource product. Afr J Pharm Pharmacol. 2020;14(7):212-220. doi:10.5897/AJPP2020.5130'}, {'Citation': 'Godoy BZ, Faintuch J, Marin ML, Nogueira MA, Pinto VB, Pollara WM. Off label pharmacological therapy in patients with short bowel syndrome. Eur Rev Med Pharmacol Sci. 2013;17(24):3285-3290.'}, {'Citation': 'Faye E, Corcos O, Bergmann JF, Simoneau G, Joly F, Lloret-Linares C. Utilisation des médicaments par voie orale et syndrome de grêle court: analyse des pratiques. Therapies. 2014;69(3):207-212. doi:10.2515/therapie/2014024'}, {'Citation': 'Vorre MM, Johansson KS, Fuglsang KA, et al. Drug use in patients with short bowel syndrome and intestinal failure. Dan Medical J. 2022;69(5):A12210940.'}, {'Citation': 'De Winter S, Spriet I, Indevuyst C, et al. Pharmacist- versus physician-acquired medication history: a prospective study at the emergency department. Qual Saf Health Care. 2010;19(5):371-375. doi:10.1136/qshc.2009.035014'}, {'Citation': 'Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. JCE. 2012;65(9):989-995. doi:10.1016/j.jclinepi.2012.02.018'}, {'Citation': 'Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.'}, {'Citation': 'US Food & Drug Administration (FDA). Drugs@FDA glossary. Accessed September 1, 2022. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=glossary.page#:~:text=A%20drug%20product%20is%20the,FDA%20Application%20Number'}, {'Citation': 'Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res. 2005;22(1):11-23. doi:10.1007/s11095-004-9004-4'}, {'Citation': 'Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharmaceut Biopharmaceut. 2004;58(2):265-278. doi:10.1016/j.ejpb.2004.03.001'}, {'Citation': 'Bergström CAS, Strafford M, Lazorova L, Avdeef A, Luthman K, Artursson P. Absorption classification of oral drugs based on molecular surface properties. J Med Chem. 2003;46(4):558-570. doi:10.1021/jm020986i'}, {'Citation': 'Plöger GF, Hofsäss MA, Dressman JB. Solubility determination of active pharmaceutical ingredients which have been recently added to the list of essential medicines in the context of the Biopharmaceutics Classification System-biowaiver. J Pharm Sci. 2018;107(6):1478-1488. doi:10.1016/j.xphs.2018.01.025'}, {'Citation': 'The Drug Delivery Foundation. BCS Database. Accessed December 22, 2019. http://www.ddfint.org/bcs-about'}, {'Citation': 'Drugdataexpy. BCS database. Accessed November 1, 2021, https://data.yaozh.com/bcs'}, {'Citation': 'Billiauws L, Maggiori L, Joly F, Panis Y. Medical and surgical management of short bowel syndrome. J Visc Surg. 2018;155(4):283-291. doi:10.1016/j.jviscsurg.2017.12.012'}, {'Citation': 'Billiauws L, Cohen M, Cazals-Hatem D, Joly F. Small intestine motility disorders: chronic intestinal pseudo-obstruction. J Visc Surg. 2022;159(1s):S22-S27. doi:10.1016/j.jviscsurg.2022.01.001'}, {'Citation': 'Allan PJ, Lal S. Metabolic bone diseases in intestinal failure. J Hum Nutr Diet. 2020;33(3):423-430. doi:10.1111/jhn.1272.6'}, {'Citation': 'Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf. 2020;11:2042098620933741. doi:10.1177/2042098620933741'}, {'Citation': 'Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother. 2018;52(9):829-837. doi:10.1177/1060028018765159'}, {'Citation': 'Rodríguez-Monguió R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003;21(9):623-650. doi:10.2165/00019053-200321090-00002'}, {'Citation': 'Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM, HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890-1896. doi:10.1001/archinternmed.2008.3'}, {'Citation': 'Digital NHS. Prescription cost analysis-England, 2018 [PAS]. Published March 28, 2019. Accessed December 13, 2022. https://digital.nhs.uk/data-and-information/publications/statistical/prescription-cost-analysis/2018'}, {'Citation': ""Vasant DH, Pironi L, Barbara G, et al. An international survey on clinicians' perspectives on the diagnosis and management of chronic intestinal pseudo-obstruction and enteric dysmotility. Neurogastroenterol Motil. 2020;32(12):e13937. doi:10.1111/nmo.13937""}, {'Citation': 'Iyer K, DiBaise JK, Rubio-Tapia A. AGA clinical practice update on management of short bowel syndrome: expert review. Clin Gastroenterol Hepatol. 2022;20(10):2185-2194. doi:10.1016/j.cgh.2022.05.032'}, {'Citation': 'Titus R, Kastenmeier A, Otterson MF. Consequences of gastrointestinal surgery on drug absorption. Nutr Clin Pract. 2013;28(4):429-436. doi:10.1177/0884533613490740'}, {'Citation': 'Benet LZ, Broccatelli F, Oprea TI. BDDCS applied to over 900 drugs. AAPS J. 2011;13(4):519-547. doi:10.1208/s12248-011-9290-9'}, {'Citation': 'Benet LZ. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development. J Pharm Sci. 2013;102(1):34-42. doi:10.1002/jps.23359'}, {'Citation': 'Verbiest A, Wauters L, Vanuytsel T. Enterohormone therapy for short bowel syndrome. Curr Opin Endocrinol Diabetes Obes. 2022;29(2):207-218. doi:10.1097/med.0000000000000710'}, {'Citation': 'Wilson IB, Carter AE, Berg KM. Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty. Curr HIV/AIDS Rep. 2009;6(4):177-186. doi:10.1007/s11904-009-0024-x'}], 'Title': 'REFERENCES'}], 'History': [DictElement({'Year': '2023', 'Month': '6', 'Day': '20'}, attributes={'PubStatus': 'revised'}), DictElement({'Year': '2023', 'Month': '4', 'Day': '2'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2023', 'Month': '7', 'Day': '23'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '0', 'Minute': '42'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '0', 'Minute': '42'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '22', 'Minute': '54'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'aheadofprint', 'ArticleIdList': [StringElement('37604787', attributes={'IdType': 'pubmed'}), StringElement('10.1002/ncp.11065', attributes={'IdType': 'doi'})]}",37604787,Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition,Deleenheer
"Effect of single versus multiple prophylactic antibiotic doses on prosthetic joint infections following primary total hip arthroplasty in patients with osteoarthritis at public and private hospitals in Denmark: protocol for a nationwide cross-over, cluster randomised, non-inferiority trial [The Pro-Hip-Quality Trial].","[StringElement('A feared complication after total hip arthroplasty (THA) is prosthetic joint infection (PJI), associated with high morbidity and mortality. Prophylactic antibiotics can reduce the risk of PJI. However, there is no consensus on the dosages and current recommendations are based on a low evidence level. The objective is to compare the effect of a single versus multiple doses of prophylactic antibiotics administered within 24 hours on PJI.', attributes={'Label': 'INTRODUCTION', 'NlmCategory': 'BACKGROUND'}), StringElement('The study is designed as a cross-over, cluster randomised, non-inferiority trial. All clinical centres use both antibiotic practices (1\u2009year of each intervention). All Danish orthopaedic surgery departments will be involved: Based on quality databases, 2-year cohorts of approximately 20\u2009000 primary THAs conducted at 39 public and private hospitals, will be included.', attributes={'Label': 'METHODS AND ANALYSIS', 'NlmCategory': 'METHODS'}), StringElement('age ≥18 years, all indications for THA except patients operated due to acute or sequelae from proximal femoral or pelvic fractures or bone tumour or metastasis. The primary outcome is PJI within 90 days after primary THA. Secondary outcomes include (1) serious adverse events, (2) potential PJI, (3) length of hospitalisation stay, (4) cardiovascular events, (5) hospital-treated infections, (6) community-based antibiotic use, (7) opioid use and (8) use of acetaminophen and non-steroidal anti-inflammatory drugs. All outcome measures will be extracted from national databases. Analyses will be based on the intention-to-treat population. Non-inferiority will be shown if the upper limit of the two-sided 95% CI for the OR is less than 1.32 for the single dose as compared with multiple doses. The results will establish best practice on antibiotic prophylaxis dosages in the future.', attributes={'Label': 'INCLUSION CRITERIA', 'NlmCategory': 'METHODS'}), StringElement('This study has been approved by Committees on Health Research Ethics for The Capital Region of Denmark (21069108) and The Danish Medicines Agency (2021091723). All results will be presented in peer-reviewed medical journals and international conferences.', attributes={'Label': 'ETHICS AND DISSEMINATION', 'NlmCategory': 'BACKGROUND'}), StringElement('NCT05530551.', attributes={'Label': 'TRIAL REGISTRATION NUMBER', 'NlmCategory': 'BACKGROUND'})]",Armita Armina,"{'ReferenceList': [], 'History': [DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '0', 'Minute': '42'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '0', 'Minute': '42'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '21', 'Minute': '3'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('37604637', attributes={'IdType': 'pubmed'}), StringElement('10.1136/bmjopen-2022-071487', attributes={'IdType': 'doi'}), StringElement('bmjopen-2022-071487', attributes={'IdType': 'pii'})]}",37604637,BMJ open,Abedi
"Graphene/metal-organic framework nano-sandwiches derived N, P-codoped porous carbon nanosheets as robust material for electrochemical analysis.","[""Construction of novel two-dimensional porous carbon nanosheets with superior electrochemical activity is of great challenge. Here, graphene/ZIF-8 nano-sandwiches derived N, P-codoped porous carbon nanosheets (N, P-codoped PCN) was easily obtained by sequential room temperature self-assembly and high-temperature carbonization method. Relative to the widely used physically exfoliated graphene nanosheets (GN) and graphene/ZIF-8 derived N-doped porous carbon nanosheets (N-doped PCN), N, P-codoped PCN displayed larger active surface, faster electron transport ability and stronger physical adsorption ability, which can be ascribed to the dual doping effect of heteroatoms N and P. As a result, N, P-codoped PCN exhibited remarkable oxidation signal enhancement for tumor marker (8-hydroxy-2'-deoxyguanosine), analgesic and antipyretic drug (acetaminophen) and organic pesticide (benomyl). Besides, the limits of detection were measured as low as 1.58\xa0nM, 7.50\xa0nM and 2.10\xa0nM with sensitivity of 270.00\xa0μA\xa0μM<sup>-1</sup>\xa0cm<sup>-2</sup>, 757.14\xa0μA\xa0μM<sup>-1</sup>\xa0cm<sup>-2</sup> and 272.86\xa0μA\xa0μM<sup>-1</sup>\xa0cm<sup>-2</sup> for 8-hydroxy-2'-deoxyguanosine, acetaminophen and benomyl, respectively. Basing on this, a novel and highly sensitive electrochemical sensing platform was developed. It is believed that the reported two-dimensional N, P-codoped PCN with unique structure and composition is highly valuable for the development of carbon-based electrochemical sensors.""]",Shiyu,"{'ReferenceList': [], 'History': [DictElement({'Year': '2023', 'Month': '6', 'Day': '27'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2023', 'Month': '7', 'Day': '23'}, attributes={'PubStatus': 'revised'}), DictElement({'Year': '2023', 'Month': '7', 'Day': '29'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '0', 'Minute': '42'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '0', 'Minute': '41'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '20', 'Minute': '56'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'ppublish', 'ArticleIdList': [StringElement('37604626', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.aca.2023.341675', attributes={'IdType': 'doi'}), StringElement('S0003-2670(23)00896-6', attributes={'IdType': 'pii'})]}",37604626,Analytica chimica acta,Tang
"Discovery of hepatoprotective activity components from Thymus quinquecostatus celak. by molecular networking, biological evaluation and molecular dynamics studies.","[""Thymus quinquecostatus Celak. is an edible herb that widely cultivated in Asia and possesses hepatoprotective activity, but the underlying non-volatile components of this protective activity are not well studied. In this study, combining molecular networking visualization and bioassay-guided fractionation strategies, a pair of novel skeleton diterpenoid enantiomers, (+)- and (-)-thymutatusone A [(+)- and (-)-1], along with one new and one known biogenetically related compounds (2-3) and 16 other known compounds (4-19), were identified from T. quinquecostatus. Their structures were exhaustively characterized by comprehensive spectroscopic data, X-ray diffraction analysis, and ECD calculations. Compounds (±)-1, (-)-1, and (+)-1, with a rare tricyclo [7.3.1.0<sup>2,7</sup>] tridecane skeleton, exhibited potent hepatoprotective activity in HepG2 cells injured by acetaminophen, with EC<sub>50</sub> values of 11.5\xa0±\xa02.8, 8.4\xa0±\xa01.9, and 12.2\xa0±\xa00.3\xa0μM respectively. They were more potent than positive drug bifendate (EC<sub>50</sub> 15.2\xa0±\xa01.3). Further, the underlying mechanism for the hepatoprotective activity of compound (-)-1 related to activating the Nrf 2 signaling pathway. What's more, molecular docking and molecular dynamics simulation analysis showed that compound (-)-1 could dock with the active site of Nrf 2 protein and form a stable system through hydrogen bonding. These results suggest that T. quinquecostatus can be used as a valuable source of hepatoprotective activity compounds.""]",Xiangjian,"{'ReferenceList': [], 'History': [DictElement({'Year': '2023', 'Month': '7', 'Day': '14'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '4'}, attributes={'PubStatus': 'revised'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '14'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '0', 'Minute': '42'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '22', 'Hour': '0', 'Minute': '42'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '18', 'Minute': '8'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'aheadofprint', 'ArticleIdList': [StringElement('37604095', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.bioorg.2023.106790', attributes={'IdType': 'doi'}), StringElement('S0045-2068(23)00451-0', attributes={'IdType': 'pii'})]}",37604095,Bioorganic chemistry,Zhong
Maturation of Paracetamol Elimination Routes in Preterm Neonates Born Below 32 Weeks of Gestation.,"[StringElement('Despite being off-label, intravenous paracetamol (PCM) is increasingly used to control mild-to-moderate pain in preterm neonates. Here we aim to quantify the maturation of paracetamol elimination pathways in preterm neonates born below 32\xa0weeks of gestation.', attributes={'Label': 'PURPOSE', 'NlmCategory': 'OBJECTIVE'}), StringElement('Datasets after single dose (rich data) or multiple doses (sparse data) of intravenous PCM dose (median (range)) 9 (3-25) mg/kg were pooled, containing 534 plasma and 44 urine samples of PCM and metabolites (PCM-glucuronide, PCM-sulfate, PCM-cysteine, and PCM-mercapturate) from 143 preterm neonates (gestational age 27.7 (24.0-31.9) weeks, birthweight 985 (462-1,925) g, postnatal age (PNA) 5 (0-30) days, current weight 1,012 (462-1,959) g. Population pharmacokinetic analysis was performed using NONMEM® 7.4.', attributes={'Label': 'METHODS', 'NlmCategory': 'METHODS'}), StringElement('For a typical preterm neonate (birthweight 985\xa0g; PNA 5\xa0days), PCM clearance was 0.137 L/h, with glucuronidation, sulfation, oxidation and unchanged renal clearance accounting for 5.3%, 73.7%, 16.3% and 4.6%, respectively. Maturational changes in total PCM clearance and its elimination pathways were best described by birthweight and PNA. Between 500-1,500\xa0g birthweight, total PCM clearance increases by 169%, with glucuronidation, sulfation and oxidation clearance increasing by 347%, 164% and 164%. From 1-30\xa0days PNA for 985 g birthweight neonate, total PCM clearance increases by 167%, with clearance via glucuronidation and oxidation increasing by 551%, and sulfation by 69%.', attributes={'Label': 'RESULTS', 'NlmCategory': 'RESULTS'}), StringElement('Birthweight and PNA are the most important predictors for maturational changes in paracetamol clearance and its glucuronidation, sulfation and oxidation. As a result, dosing based on bodyweight alone will not lead to consistent paracetamol concentrations among preterm neonates.', attributes={'Label': 'CONCLUSION', 'NlmCategory': 'CONCLUSIONS'})]",Yunjiao,"{'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Cuzzolin L, Antonucci R, Fanos V. Paracetamol (acetaminophen) efficacy and safety in the newborn. Curr Drug Metab. 2013;14(2):178–85.', 'ArticleIdList': [StringElement('22935063', attributes={'IdType': 'pubmed'})]}, {'Citation': 'ten Barge JA, et al. Current pain management practices for preterm infants with necrotizing enterocolitis: a European survey. Pediatr Res. 2023;94:555–63.', 'ArticleIdList': [StringElement('36828969', attributes={'IdType': 'pubmed'}), StringElement('10382315', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41390-023-02508-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Prescott LF. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol. 1980;10 Suppl 2(Suppl 2):291s–8s.', 'ArticleIdList': [StringElement('7002186', attributes={'IdType': 'pubmed'}), StringElement('10.1111/j.1365-2125.1980.tb01812.x', attributes={'IdType': 'doi'})]}, {'Citation': 'Gelotte CK, et al. Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharmacol Ther. 2007;81(6):840–8.', 'ArticleIdList': [StringElement('17377528', attributes={'IdType': 'pubmed'}), StringElement('10.1038/sj.clpt.6100121', attributes={'IdType': 'doi'})]}, {'Citation': 'Miller RP, Roberts RJ, Fischer LJ. Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther. 1976;19(3):284–94.', 'ArticleIdList': [StringElement('1261167', attributes={'IdType': 'pubmed'}), StringElement('10.1002/cpt1976193284', attributes={'IdType': 'doi'})]}, {'Citation': 'Allegaert K, et al. In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age. Ther Drug Monit. 2009;31(4):411–5.', 'ArticleIdList': [StringElement('19494793', attributes={'IdType': 'pubmed'}), StringElement('10.1097/FTD.0b013e3181a8cc0a', attributes={'IdType': 'doi'})]}, {'Citation': 'Krekels EH, et al. Developmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants. Eur J Clin Pharmacol. 2015;71(9):1075–82.', 'ArticleIdList': [StringElement('26139379', attributes={'IdType': 'pubmed'}), StringElement('4532713', attributes={'IdType': 'pmc'}), StringElement('10.1007/s00228-015-1887-y', attributes={'IdType': 'doi'})]}, {'Citation': 'Cook SF, et al. Population pharmacokinetics of intravenous paracetamol (Acetaminophen) in preterm and term neonates: model development and external evaluation. Clin Pharmacokinet. 2016;55(1):107–19.', 'ArticleIdList': [StringElement('26201306', attributes={'IdType': 'pubmed'}), StringElement('5564323', attributes={'IdType': 'pmc'}), StringElement('10.1007/s40262-015-0301-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Cook SF, et al. Neonatal maturation of paracetamol (Acetaminophen) glucuronidation, sulfation, and oxidation based on a parent-metabolite population pharmacokinetic model. Clin Pharmacokinet. 2016;55(11):1395–411.', 'ArticleIdList': [StringElement('27209292', attributes={'IdType': 'pubmed'}), StringElement('5572771', attributes={'IdType': 'pmc'}), StringElement('10.1007/s40262-016-0408-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Allegaert K, Palmer GM, Anderson BJ. The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child. 2011;96(6):575–80.', 'ArticleIdList': [StringElement('21317433', attributes={'IdType': 'pubmed'}), StringElement('10.1136/adc.2010.204552', attributes={'IdType': 'doi'})]}, {'Citation': 'Palmer GM, et al. I.V. acetaminophen pharmacokinetics in neonates after multiple doses. Br J Anaesth. 2008;101(4):523–30.', 'ArticleIdList': [StringElement('18628265', attributes={'IdType': 'pubmed'}), StringElement('10.1093/bja/aen208', attributes={'IdType': 'doi'})]}, {'Citation': 'van Ganzewinkel C, et al. Multiple intravenous doses of paracetamol result in a predictable pharmacokinetic profile in very preterm infants. Acta Paediatr. 2014;103(6):612–7.', 'ArticleIdList': [StringElement('24654967', attributes={'IdType': 'pubmed'}), StringElement('10.1111/apa.12638', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang C, et al. Population pharmacokinetics of paracetamol across the human age-range from (pre)term neonates, infants, children to adults. J Clin Pharmacol. 2014;54(6):619–29.', 'ArticleIdList': [StringElement('24375166', attributes={'IdType': 'pubmed'}), StringElement('10.1002/jcph.259', attributes={'IdType': 'doi'})]}, {'Citation': 'Anderson BJ, et al. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatr Anaesth. 2005;15(4):282–92.', 'ArticleIdList': [StringElement('15787918', attributes={'IdType': 'pubmed'}), StringElement('10.1111/j.1460-9592.2005.01455.x', attributes={'IdType': 'doi'})]}, {'Citation': 'Flint RB, et al. Exposure to acetaminophen and all its metabolites upon 10, 15, and 20 mg/kg intravenous acetaminophen in very-preterm infants. Pediatr Res. 2017;82(4):678–84.', 'ArticleIdList': [StringElement('28553988', attributes={'IdType': 'pubmed'}), StringElement('10.1038/pr.2017.129', attributes={'IdType': 'doi'})]}, {'Citation': 'Cook SF, et al. Simultaneous quantification of acetaminophen and five acetaminophen metabolites in human plasma and urine by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry: method validation and application to a neonatal pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1007:30–42.', 'ArticleIdList': [StringElement('26571452', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.jchromb.2015.10.013', attributes={'IdType': 'doi'})]}, {'Citation': 'Flint RB, et al. Quantification of acetaminophen and its metabolites in plasma using UPLC-MS: doors open to therapeutic drug monitoring in special patient populations. Ther Drug Monit. 2017;39(2):164–71.', 'ArticleIdList': [StringElement('28169862', attributes={'IdType': 'pubmed'}), StringElement('10.1097/FTD.0000000000000379', attributes={'IdType': 'doi'})]}, {'Citation': 'Hoftiezer L, et al. From population reference to national standard: new and improved birthweight charts. Am J Obstet Gynecol. 2019;220(4):383.e1-383.e17.', 'ArticleIdList': [StringElement('30576661', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.ajog.2018.12.023', attributes={'IdType': 'doi'})]}, {'Citation': 'Comets E, Brendel K, Mentré F. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput Methods Programs Biomed. 2008;90(2):154–66.', 'ArticleIdList': [StringElement('18215437', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.cmpb.2007.12.002', attributes={'IdType': 'doi'})]}, {'Citation': 'Mian P, et al. Intravenous paracetamol dosing guidelines for pain management in (pre)term neonates using the paediatric study decision tree. Curr Pharm Des. 2017;23(38):5839–49.', 'ArticleIdList': [StringElement('28933266', attributes={'IdType': 'pubmed'}), StringElement('10.2174/1381612823666170921143104', attributes={'IdType': 'doi'})]}, {'Citation': 'Anchieta LM, et al. Weight of preterm newborns during the first twelve weeks of life. Braz J Med Biol Res. 2003;36(6):761–70.', 'ArticleIdList': [StringElement('12792706', attributes={'IdType': 'pubmed'}), StringElement('10.1590/S0100-879X2003000600012', attributes={'IdType': 'doi'})]}, {'Citation': 'Court MH, et al. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther. 2001;299(3):998–1006.', 'ArticleIdList': [StringElement('11714888', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Allegaert K, et al. Intra- and interindividual variability of glucuronidation of paracetamol during repeated administration of propacetamol in neonates. Acta Paediatr. 2005;94(9):1273–9.', 'ArticleIdList': [StringElement('16278989', attributes={'IdType': 'pubmed'}), StringElement('10.1111/j.1651-2227.2005.tb02088.x', attributes={'IdType': 'doi'})]}, {'Citation': 'van Lingen RA, et al. Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80(1):F59-63.', 'ArticleIdList': [StringElement('10325815', attributes={'IdType': 'pubmed'}), StringElement('1720876', attributes={'IdType': 'pmc'}), StringElement('10.1136/fn.80.1.F59', attributes={'IdType': 'doi'})]}, {'Citation': 'Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344(8):581–90.', 'ArticleIdList': [StringElement('11207355', attributes={'IdType': 'pubmed'}), StringElement('10.1056/NEJM200102223440807', attributes={'IdType': 'doi'})]}, {'Citation': 'Bhatt DK, et al. Age- and genotype-dependent variability in the protein abundance and activity of six major uridine diphosphate-glucuronosyltransferases in human liver. Clin Pharmacol Ther. 2019;105(1):131–41.', 'ArticleIdList': [StringElement('29737521', attributes={'IdType': 'pubmed'}), StringElement('10.1002/cpt.1109', attributes={'IdType': 'doi'})]}, {'Citation': 'Yamamoto A, et al. Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. J Biochem. 2015;158(6):497–504.', 'ArticleIdList': [StringElement('26067475', attributes={'IdType': 'pubmed'}), StringElement('4819960', attributes={'IdType': 'pmc'})]}, {'Citation': 'Adjei AA, et al. Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol. 2008;82(3):155–65.', 'ArticleIdList': [StringElement('18232020', attributes={'IdType': 'pubmed'}), StringElement('10.1002/bdra.20535', attributes={'IdType': 'doi'})]}, {'Citation': 'Duanmu Z, et al. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther. 2006;316(3):1310–7.', 'ArticleIdList': [StringElement('16339912', attributes={'IdType': 'pubmed'}), StringElement('10.1124/jpet.105.093633', attributes={'IdType': 'doi'})]}, {'Citation': 'Hendrix-Treacy S, et al. The effect of acetaminophen administration on its disposition and body stores of sulphate. Eur J Clin Pharmacol. 1986;30(3):273–8.', 'ArticleIdList': [StringElement('3732362', attributes={'IdType': 'pubmed'}), StringElement('10.1007/BF00541527', attributes={'IdType': 'doi'})]}, {'Citation': 'Gastrup S, et al. Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects. Br J Clin Pharmacol. 2016;81(4):735–41.', 'ArticleIdList': [StringElement('26588196', attributes={'IdType': 'pubmed'}), StringElement('4799936', attributes={'IdType': 'pmc'}), StringElement('10.1111/bcp.12840', attributes={'IdType': 'doi'})]}, {'Citation': 'Li J, et al. Sulfate conjugation may be the key to hepatotoxicity in paracetamol overdose. Br J Clin Pharmacol. 2021;87(5):2392–6.', 'ArticleIdList': [StringElement('33179287', attributes={'IdType': 'pubmed'}), StringElement('10.1111/bcp.14642', attributes={'IdType': 'doi'})]}, {'Citation': 'Liu L, Klaassen CD. Different mechanism of saturation of acetaminophen sulfate conjugation in mice and rats. Toxicol Appl Pharmacol. 1996;139(1):128–34.', 'ArticleIdList': [StringElement('8685895', attributes={'IdType': 'pubmed'}), StringElement('10.1006/taap.1996.0151', attributes={'IdType': 'doi'})]}, {'Citation': 'McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 2013;30(9):2174–87.', 'ArticleIdList': [StringElement('23462933', attributes={'IdType': 'pubmed'}), StringElement('3709007', attributes={'IdType': 'pmc'}), StringElement('10.1007/s11095-013-1007-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Johnsrud EK, et al. Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther. 2003;307(1):402–7.', 'ArticleIdList': [StringElement('14500779', attributes={'IdType': 'pubmed'}), StringElement('10.1124/jpet.103.053124', attributes={'IdType': 'doi'})]}, {'Citation': 'Kalsi SS, et al. A review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdose. Open Access Emerg Med. 2011;3:87–96.', 'ArticleIdList': [StringElement('27147856', attributes={'IdType': 'pubmed'}), StringElement('4753970', attributes={'IdType': 'pmc'})]}, {'Citation': 'Locci C, et al. Paracetamol overdose in the newborn and infant: a life-threatening event. Eur J Clin Pharmacol. 2021;77(6):809–15.', 'ArticleIdList': [StringElement('33388821', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s00228-020-03077-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Kalsi SS, et al. Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose? Open Access Emerg Med. 2011;3:69–76.', 'ArticleIdList': [StringElement('27147854', attributes={'IdType': 'pubmed'}), StringElement('4753969', attributes={'IdType': 'pmc'})]}, {'Citation': 'Roofthooft DWE, et al. Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure. Eur J Pediatr. 2015;174(11):1433–40.', 'ArticleIdList': [StringElement('25922139', attributes={'IdType': 'pubmed'}), StringElement('4623081', attributes={'IdType': 'pmc'}), StringElement('10.1007/s00431-015-2541-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Allegaert K, et al. The paracetamol concentration-effect relation in neonates. Pediatr Anesth. 2013;23(1):45–50.', 'ArticleIdList': [StringElement('10.1111/pan.12076', attributes={'IdType': 'doi'})]}, {'Citation': 'Patel R, et al. Long-term safety of prenatal and neonatal exposure to paracetamol: a systematic review. Int J Environ Res Public Health. 2022;19(4):2128.', 'ArticleIdList': [StringElement('35206317', attributes={'IdType': 'pubmed'}), StringElement('8871754', attributes={'IdType': 'pmc'}), StringElement('10.3390/ijerph19042128', attributes={'IdType': 'doi'})]}, {'Citation': 'Cohen IV, et al. Acetaminophen (Paracetamol) Use Modifies the Sulfation of Sex Hormones. EBioMedicine. 2018;28:316–23.', 'ArticleIdList': [StringElement('29398597', attributes={'IdType': 'pubmed'}), StringElement('5835573', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ebiom.2018.01.033', attributes={'IdType': 'doi'})]}, {'Citation': 'Linakis MW, et al. Polymorphic expression of UGT1A9 is associated with variable acetaminophen glucuronidation in neonates: a population pharmacokinetic and pharmacogenetic study. Clin Pharmacokinet. 2018;57(10):1325–36.', 'ArticleIdList': [StringElement('29654492', attributes={'IdType': 'pubmed'}), StringElement('6785200', attributes={'IdType': 'pmc'}), StringElement('10.1007/s40262-018-0634-9', attributes={'IdType': 'doi'})]}]}], 'History': [DictElement({'Year': '2023', 'Month': '4', 'Day': '19'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2023', 'Month': '7', 'Day': '26'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '12', 'Minute': '42'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '12', 'Minute': '42'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '11', 'Minute': '7'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'aheadofprint', 'ArticleIdList': [StringElement('37603141', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s11095-023-03580-3', attributes={'IdType': 'doi'}), StringElement('10.1007/s11095-023-03580-3', attributes={'IdType': 'pii'})]}",37603141,Pharmaceutical research,Wu
Efficacy of Transversus Abdominis Plane Block for Postoperative Analgesia in Different Lower Abdominal Surgeries in a Tertiary Care Hospital-Chengalpattu District.,"[StringElement('Transversus abdominis plane (TAP) block is one of the novel approaches and an effective method for providing postoperative analgesia in patients undergoing lower abdominal surgeries.', attributes={'Label': 'BACKGROUND', 'NlmCategory': 'UNASSIGNED'}), StringElement('To evaluate the efficacy and routine usage of TAP block for postoperative analgesia in different lower abdominal surgeries.', attributes={'Label': 'OBJECTIVES', 'NlmCategory': 'UNASSIGNED'}), StringElement('It is a randomized, double-blind trial. Sixty patients undergoing lower abdominal surgeries in sub-arachnoid block with bupivicaine 0.5% were randomized to undergo TAP block (n = 30) using ropivacaine 0.375% as the study group. In the control group (n = 30), only the standard analgesic regimen (paracetamol 1 gm IV and tramadol 50 mg IV) was given. Postoperative pain was assessed using Visual Analogue Scale (VAS) at 30 min and 4, 8, 12, 16, 20, and 24 hrs. First analgesic request after TAP block was compared with a subsequent number of analgesics given postoperatively. Rescue analgesia given postoperatively at request after TAP block was paracetamol 1 gm IV and tramadol 50 mg IV.', attributes={'Label': 'METHODS', 'NlmCategory': 'UNASSIGNED'}), StringElement('Patients who received TAP block had a significant reduction in postoperative pain scores at 30 min - 0 (0 - 1), 4 hrs - 0 (0 - 4), 8 hrs - 4 (3 - 5), 12 hrs - 1 (0 - 4), 16 hrs - 1 (1 - 2), 20 hrs -1 (0 - 2), 24 hrs -1 (0 - 1) with P-value < 0.05 in the first 24 hrs. TAP block also delayed the first rescue analgesic request (265 ± 24 min Vs. 66 ± 15 min with P-value < 0.005) and reduction in subsequent analgesic requirements in the first 24 hrs (1.04 ± 0.26 Vs. 2.3 ± 0.48 with P-value < 0.05).', attributes={'Label': 'RESULTS', 'NlmCategory': 'UNASSIGNED'}), StringElement('TAP block holds a considerable part in postoperative analgesia. Highly effective for the first 24 hrs in patients undergoing different lower abdominal surgeries, it delays the first rescue analgesic request, decreases the subsequent analgesic requirement, and augments early mobilization, discharge, and cost-effectiveness.', attributes={'Label': 'CONCLUSIONS', 'NlmCategory': 'UNASSIGNED'})]",Murali Manoj,"{'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Wall PD, Melzack R. Pain measurements in persons in pain. In: Wall PD, Melzack R, editors. Textbook of pain. 4th ed. Edinburgh, UK: Churchill Livingstone; 1999.'}, {'Citation': 'Netter FH. Back and spinal cord . In: Netter FH, editor. Atlas of human anatomy summit. New Jersey, USA: Ciba-Geigy Corporation; 1989. pp. 145–55.'}, {'Citation': 'Dierking GW, Dahl JB, Kanstrup J, Dahl A, Kehlet H. Effect of pre- vs postoperative inguinal field block on postoperative pain after herniorrhaphy. Br J Anaesth. 1992;68(4):344–8. doi: 10.1093/bja/68.4.344.', 'ArticleIdList': [StringElement('10.1093/bja/68.4.344', attributes={'IdType': 'doi'}), StringElement('1642910', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kuppuvelumani P, Jaradi H, Delilkan A. Abdominal nerve blockade for postoperative analgesia after caesarean section. Asia Oceania J Obstet Gynaecol. 1993;19(2):165–9. doi: 10.1111/j.1447-0756.1993.tb00368.x.', 'ArticleIdList': [StringElement('10.1111/j.1447-0756.1993.tb00368.x', attributes={'IdType': 'doi'}), StringElement('8379864', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rafi AN. Abdominal field block: A new approach via the lumbar triangle. Anaesthesia. 2001;56(10):1024–6. doi: 10.1046/j.1365-2044.2001.02279-40.x.', 'ArticleIdList': [StringElement('10.1046/j.1365-2044.2001.02279-40.x', attributes={'IdType': 'doi'}), StringElement('11576144', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Netter FH. Abdomen posterolateral abdominal wall. In: Netter FH, editor. Atlas of human anatomy summit. New Jersey, USA: Ciba-Geigy Corporation; 1989. pp. 230–40.'}, {'Citation': 'McDonnell JG, O’Donnell BD, Tuite D, Farrell T, Power C. The regional abdominal field infiltration (RAFI) technique: Computerised tomographic and anatomical identification of a novel approach to the transversus abdominis neuro-vascular fascial plane. Anesth. 2004;101:A899'}, {'Citation': 'Cho S, Kim YJ, Lee M, Woo JH, Lee HJ. Cut-off points between pain intensities of the postoperative pain using receiver operating characteristic (ROC) curves. BMC Anesthesiol. 2021;21(1):29. doi: 10.1186/s12871-021-01245-5.', 'ArticleIdList': [StringElement('10.1186/s12871-021-01245-5', attributes={'IdType': 'doi'}), StringElement('PMC7831264', attributes={'IdType': 'pmc'}), StringElement('33494704', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Sforza M, Andjelkov K, Zaccheddu R, Nagi H, Colic M. Transversus abdominis plane block anesthesia in abdominoplasties. Plast Reconstr Surg. 2011;128(2):529–35. doi: 10.1097/PRS.0b013e31821e6f51.', 'ArticleIdList': [StringElement('10.1097/PRS.0b013e31821e6f51', attributes={'IdType': 'doi'}), StringElement('21788846', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kehlet H. Surgical stress: The role of pain and analgesia. Br J Anaesth. 1989;63(2):189–95. doi: 10.1093/bja/63.2.189.', 'ArticleIdList': [StringElement('10.1093/bja/63.2.189', attributes={'IdType': 'doi'}), StringElement('2669908', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kehlet H, Holte K. Effect of postoperative analgesia on surgical outcome. Br J Anaesth. 2001;87(1):62–72. doi: 10.1093/bja/87.1.62.', 'ArticleIdList': [StringElement('10.1093/bja/87.1.62', attributes={'IdType': 'doi'}), StringElement('11460814', attributes={'IdType': 'pubmed'})]}, {'Citation': ""Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999;91(1):8–15. doi: 10.1097/00000542-199907000-00006."", 'ArticleIdList': [StringElement('10.1097/00000542-199907000-00006', attributes={'IdType': 'doi'}), StringElement('10422923', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Liu SS, Richman JM, Thirlby RC, Wu CL. Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: A quantitative and qualitative systematic review of randomized controlled trials. J Am Coll Surg. 2006;203(6):914–32. doi: 10.1016/j.jamcollsurg.2006.08.007.', 'ArticleIdList': [StringElement('10.1016/j.jamcollsurg.2006.08.007', attributes={'IdType': 'doi'}), StringElement('17116561', attributes={'IdType': 'pubmed'})]}, {'Citation': 'White PF. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth Analg. 2005;101(5 Suppl):S5–S22. doi: 10.1213/01.ANE.0000177099.28914.A7.', 'ArticleIdList': [StringElement('10.1213/01.ANE.0000177099.28914.A7', attributes={'IdType': 'doi'}), StringElement('16334489', attributes={'IdType': 'pubmed'})]}, {'Citation': ""O'Donnell BD, McDonnell JG, McShane AJ. The transversus abdominis plane (TAP) block in open retropubic prostatectomy. Reg Anesth Pain Med. 2006;31(1):91. doi: 10.1016/j.rapm.2005.10.006."", 'ArticleIdList': [StringElement('10.1016/j.rapm.2005.10.006', attributes={'IdType': 'doi'}), StringElement('16418039', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jankovic Z, Ahmad N, Ravishankar N, Archer F. Transversus abdominis plane block: How safe is it? Anesth Analg. 2008;107(5):1758–9. doi: 10.1213/ane.0b013e3181853619.', 'ArticleIdList': [StringElement('10.1213/ane.0b013e3181853619', attributes={'IdType': 'doi'}), StringElement('18931248', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Niraj G, Searle A, Mathews M, Misra V, Baban M, Kiani S, et al. Analgesic efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing open appendicectomy. Br J Anaesth. 2009;103(4):601–5. doi: 10.1093/bja/aep175.', 'ArticleIdList': [StringElement('10.1093/bja/aep175', attributes={'IdType': 'doi'}), StringElement('19561014', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Khan SM, Nawaz S, Delvi MB, Alzahrani T, Thallaj A, Zubaidi A, et al. Intraoperative ultrasound-guided transversus abdominis plane block in lower abdominal surgery. International Journal of Perioperative Ultrasound and Applied Technologies. 2012;1:1–4. doi: 10.5005/jp-journals-10027-1001.', 'ArticleIdList': [StringElement('10.5005/jp-journals-10027-1001', attributes={'IdType': 'doi'})]}, {'Citation': 'Kaur A, Singh RB, Tripathi RK, Choubey S. Comparision between bupivacaine and ropivacaine in patients undergoing forearm surgeries under axillary brachial plexus block: A prospective randomized study. J Clin Diagn Res. 2015;9(1):UC01–6. doi: 10.7860/JCDR/2015/10556.5446.', 'ArticleIdList': [StringElement('10.7860/JCDR/2015/10556.5446', attributes={'IdType': 'doi'}), StringElement('PMC4347153', attributes={'IdType': 'pmc'}), StringElement('25738062', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Rouholamin S, Ghahiri A, Dehghan Khalili B. The efficacy of ropivacaine 0.5% in transversus abdominis plane block to relieve the postoperative pain of female laparoscopic surgery grade II. Adv Biomed Res. 2022;11:12. doi: 10.4103/abr.abr_46_20.', 'ArticleIdList': [StringElement('10.4103/abr.abr_46_20', attributes={'IdType': 'doi'}), StringElement('PMC8977607', attributes={'IdType': 'pmc'}), StringElement('35386544', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wan QX, Bo YL, Li HB, Li WZ. Effects of mixture of lidocaine and ropivacaine at different concentrations on the central nervous system and cardiovascular toxicity in rats. Chin Med J (Engl). 2010;123(1):79–83.', 'ArticleIdList': [StringElement('20137580', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Cuvillon P, Nouvellon E, Ripart J, Boyer JC, Dehour L, Mahamat A, et al. A comparison of the pharmacodynamics and pharmacokinetics of bupivacaine, ropivacaine (with epinephrine) and their equal volume mixtures with lidocaine used for femoral and sciatic nerve blocks: A double-blind randomized study. Anesth Analg. 2009;108(2):641–9. doi: 10.1213/ane.0b013e31819237f8.', 'ArticleIdList': [StringElement('10.1213/ane.0b013e31819237f8', attributes={'IdType': 'doi'}), StringElement('19151302', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Tsai HC, Yoshida T, Chuang TY, Yang SF, Chang CC, Yao HY, et al. Transversus abdominis plane block: An updated review of anatomy and techniques. Biomed Res Int. 2017;2017:8284363. doi: 10.1155/2017/8284363.', 'ArticleIdList': [StringElement('10.1155/2017/8284363', attributes={'IdType': 'doi'}), StringElement('PMC5684553', attributes={'IdType': 'pmc'}), StringElement('29226150', attributes={'IdType': 'pubmed'})]}]}], 'History': [DictElement({'Year': '2023', 'Month': '2', 'Day': '12'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2023', 'Month': '3', 'Day': '18'}, attributes={'PubStatus': 'revised'}), DictElement({'Year': '2023', 'Month': '3', 'Day': '26'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '6', 'Minute': '43'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '6', 'Minute': '42'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2023', 'Month': '8', 'Day': '21', 'Hour': '5', 'Minute': '8'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('37601961', attributes={'IdType': 'pubmed'}), StringElement('PMC10439687', attributes={'IdType': 'pmc'}), StringElement('10.5812/aapm-134864', attributes={'IdType': 'doi'})]}",37601961,Anesthesiology and pain medicine,Manoharan
